iUCC Conference 2026
Interdisciplinary Urology Care Consortium 2026 will bring together global urology experts, healthcare…
FDA Grants Priority Review for GSK’s Bepirovirsen for Chronic Hepatitis B
The FDA has granted Priority Review to GSK’s bepirovirsen for chronic hepatitis…
GSK to Acquire RAPT Therapeutics, Advancing Long-Acting IgE Therapy for Food Allergy Patients
GSK has agreed to acquire RAPT Therapeutics, adding a long-acting anti-IgE therapy…
GSK Partners with Hengrui Pharma to Advance COPD and Oncology Drug Pipeline
GSK plc announced it has entered into agreements with Hengrui Pharma to…
Abu Dhabi Launches Operations at its Regional Vaccine Distribution Hub
The Department of Health – Abu Dhabi (DoH), the regulator of the…
GSK Completes Acquisition of Efimosfermin
GSK plc announced the completion of its previously announced acquisition of efimosfermin alfa from…
NHS Pioneers World-First “Trojan Horse” Therapy for Blood Cancer: A Game-Changer for Myeloma Patients
In a groundbreaking medical milestone, the NHS in England has become the…
GSK to Advance Innovative Liver Disease Treatment with Acquisition of Efimosfermin
GSK has announced its acquisition of efimosfermin alfa, a promising new medicine…
ADGHW 2025: DoH, ADIO, and GSK sign MoU for multi-omics research institute to advance precision oncology
Abu Dhabi, UAE- 15 April 2025- During Abu Dhabi Global Health Week…
GSK announces FIRST trial met its primary endpoint of progression free survival in ovarian cancer
GSK plc (LSE/NYSE: GSK) announced headline results from the FIRST-ENGOT-OV44 phase III…
